Socias, Joyzelle Jane .
HRN: 27-31-19 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2025
CEFUROXIME 1.5GM (VIAL)
06/11/2025
06/12/2025
IV
1.5g
Q8
Pelvic Lap
Waiting Final Action
06/11/2025
CEFUROXIME 500MG (TAB)
06/12/2025
06/18/2025
PO
500mg
Bid
Pelvic Lap
Waiting Final Action
06/13/2025
CEFUROXIME 500MG (TAB)
06/13/2025
06/19/2025
PO
500mg
BID
Pelvic Lap
Waiting Final Action